Anticoagulation Therapy for Stroke Prevention
Atrial fibrillation (AF) is associated with an increased risk of stroke and appropriate management can help prevent strokes. Discover:
- The relationship between AF and stroke, and the related burdens
- Recommendations on AF screening, diagnosis, treatment, and stroke prevention
- ESC/EHRA and ACC/AHA/HRS guidelines on individualising treatment to optimise outcomes and reduce stroke risk
- Footage of expert interviews with Professors John Camm, Robert Storey and Renato Lopes
This Learning Zone reviews the epidemiology, pathophysiology, screening, diagnosis and management of atrial fibrillation, including the latest anticoagulant guidelines, to help you balance the risks and benefits of the various invasive and pharmacological options. The Learning Zone may help you deliver optimal care to help prevent strokes in your patients living with common, sustained cardiac arrhythmia.
Atrial fibrillation and stroke
AF as a risk factor for stroke
AF screening and diagnosis
Recommendations on AF screening strategies
AF treatment
AF treatment goals and strategies
Anticoagulation guidelines for AF
European and American AF guideline recommendations
Expert Opinion
Join Professor Gregory Lip (Price-Evans Chair of Cardiovascular Medicine, University of Liverpool, UK; Distinguished Professor, Aalborg University, Denmark) and Dr Marco Proietti (Assistant Professor, Internal/Geriatric Medicine, University of Milan, Italy) for their analysis on the real-world evidence for stroke prevention in atrial fibrillation (AF).
of interest
are looking at
saved
next event
This content has been developed independently by Medthority who previously received educational funding in order to help provide its healthcare professional members with access to the highest quality medical and scientific information, education and associated relevant content.